CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

NOVADOZ PHARMACEUTICALS LLC recalls Glycopyrrolate Oral Solution

Read the official FDA notice

Published
4 Feb 2026
Units affected
N/A
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

Brand / company
NOVADOZ PHARMACEUTICALS LLC
Codes / lots
Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 4 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.